These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6101671)

  • 1. gamma-Aminobutyric acid in CSF.
    Neethling AC; McCarthy B; Taljaard JJ
    Lancet; 1980 Jan; 1(8161):211. PubMed ID: 6101671
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrospinal fluid GABA levels in various neurological and psychiatric diseases.
    Kuroda H; Ogawa N; Yamawaki Y; Nukina I; Ofuji T; Yamamoto M; Otsuki S
    J Neurol Neurosurg Psychiatry; 1982 Mar; 45(3):257-60. PubMed ID: 7086447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of enzyme-mediated alterations of gamma-aminobutyric acid content in human CSF.
    Hare TA; Wood JH; Manyam BV
    Arch Neurol; 1981 Aug; 38(8):491-4. PubMed ID: 7247786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of central GABAergic activity in neurologic and psychiatric disorders: evaluation through measurements of GABA and GAD activity in cerebrospinal fluid.
    Hare TA
    Mol Cell Biochem; 1981 Sep; 39():297-304. PubMed ID: 7031462
    [No Abstract]   [Full Text] [Related]  

  • 5. Monitoring of gamma-aminobutyric acid in human cerebrospinal fluid: downward revision of previous control values.
    Löscher W; Schmidt D
    Ther Drug Monit; 1984; 6(2):227-31. PubMed ID: 6740742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary studies on CSF gamma-aminobutyric acid levels in psychiatric patients before and during treatment with different psychotropic drugs.
    Zimmer R; Teelken AW; Meier KD; Ackenheil M; Zander KJ
    Prog Neuropsychopharmacol; 1980; 4(6):613-20. PubMed ID: 7220676
    [No Abstract]   [Full Text] [Related]  

  • 7. Verification and quantification of GABA in human cerebrospinal fluid.
    Wood JH; Glaeser BS; Enna SJ; Hare TA
    J Neurochem; 1978 Jan; 30(1):291-3. PubMed ID: 621519
    [No Abstract]   [Full Text] [Related]  

  • 8. Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
    Manyam NV; Katz L; Hare TA; Gerber JC; Grossman MH
    Arch Neurol; 1980 Jun; 37(6):352-5. PubMed ID: 6446278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of freezing on gamma-aminobutyric acid levels in human cerebrospinal fluid.
    Abbott RJ; Keidan J; Pye IF; Nahorski SR
    J Neurochem; 1981 Oct; 37(4):1042-4. PubMed ID: 7320717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid gamma-aminobutyric acid in neurologic disease.
    Achar VS; Welch KM; Chabi E; Bartosh K; Meyer JS
    Neurology; 1976 Aug; 26(8):777-80. PubMed ID: 133299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-aminobutyric acid (GABA) in cerebrospinal fluid.
    Kuroda H
    Acta Med Okayama; 1983 Jun; 37(3):167-77. PubMed ID: 6224397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quantification of gamma-aminobutyric acid in the cerebrospinal fluid by a radioreceptorassay.
    Mousah H; Jacqmin P; Lesne M
    Clin Chim Acta; 1987 Dec; 170(2-3):151-9. PubMed ID: 3436050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine and gamma-aminobutyric acid in amyotrophic lateral sclerosis.
    Ziegler MG; Brooks BR; Lake CR; Wood JH; Enna SJ
    Neurology; 1980 Jan; 30(1):98-101. PubMed ID: 7188643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-aminobutyric acid levels in cerebrospinal fluid in neuropaediatric disorders.
    Cortès-Saladelafont E; Molero-Luis M; Cuadras D; Casado M; Armstrong-Morón J; Yubero D; Montoya J; Artuch R; García-Cazorla À;
    Dev Med Child Neurol; 2018 Aug; 60(8):780-792. PubMed ID: 29577258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of gamma-aminobutyric acid assay].
    Kaiya H; Nishida A
    Nihon Rinsho; 1990 Feb; 48 Suppl():109-12. PubMed ID: 2355508
    [No Abstract]   [Full Text] [Related]  

  • 16. Low CSF GABA in Parkinsonian patients who respond poorly to therapy or suffer from the "on-off" phenomenon.
    Teychenné PF; Ziegler MG; Lake CR; Enna SJ
    Ann Neurol; 1982 Jan; 11(1):76-9. PubMed ID: 6120678
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased CSF gamma-aminobutyric acid after treatment with gamma-vinyl GABA.
    Grove J; Tell G; Schechter PJ; Koch-Weser J; Warter JM; Marescaux C; Rumbach L
    Lancet; 1980 Sep; 2(8195 pt 1):647. PubMed ID: 6107437
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and biochemical effects of gamma-vinyl Gaba in tardive dyskinesia.
    Gaio JM; Pollak P; Hommel M; Perret J
    J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1674-8. PubMed ID: 3437301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of aging on cerebrospinal fluid GABA level].
    Kuroda H; Ogawa N; Nukina I; Ota Z
    Nihon Ronen Igakkai Zasshi; 1983 Nov; 20(6):500-5. PubMed ID: 6674631
    [No Abstract]   [Full Text] [Related]  

  • 20. Taurocyamine in cerebrospinal fluid of neurological and psychiatric patients.
    Wiechert P; De Deyn P; Marescau B; Lowenthal A
    J Neurol Neurosurg Psychiatry; 1986 Jun; 49(6):716-7. PubMed ID: 3734830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.